Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
29 studies found for:    Open Studies | "Goiter"
Show Display Options
Rank Status Study
1 Recruiting Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Sertoli-Leydig Cell Tumor of Ovary;   Medulloepithelioma;   Embryonal Rhabdomyosarcoma of Cervix;   Goiter;   Sarcoma;   Pineoblastoma;   Pituitary Tumors;   Wilms Tumor
Intervention:
2 Recruiting Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
Conditions: Graves Disease;   Graves Ophthalmopathy;   Graves' Ophthalmopathy Worsened
Interventions: Drug: Antithyroid Drug;   Procedure: Total thyroidectomy
3 Not yet recruiting HIFU vs RAI in the Relapsed Graves' Disease
Condition: Graves Disease
Intervention: Device: Echopulse
4 Recruiting ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy
Condition: Graves Disease
Intervention: Biological: ATX-GD-59
5 Recruiting K1-70 - A Study in Subjects With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: K1-70 intramuscular
6 Recruiting A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: CFZ533
7 Recruiting Thyroid Disease and Personality Study
Condition: Graves' Disease
Intervention: Procedure: blood sampling
8 Recruiting D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
Condition: Graves' Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
9 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
10 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
11 Not yet recruiting Glucocorticoids and Bone in Graves' Ophthalmopathy
Condition: Graves Ophthalmopathy
Intervention: Drug: Methylprednisolone
12 Recruiting Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial
Condition: Thyroid Associated Ophthalmopathy
Intervention: Drug: Glucocorticoids
13 Not yet recruiting A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy
Condition: Thyroid Associated Ophthalmopathy
Interventions: Radiation: Orbital radiotherapy;   Drug: Methylprednisolone
14 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
15 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
16 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
17 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
18 Recruiting Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Conditions: Thyrotoxicosis;   Graves Disease;   Thyroiditis
Intervention:
19 Recruiting Celecoxib for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Celecoxib;   Drug: artificial tears
20 Recruiting Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans
Conditions: Hyperthyroidism;   Tomography;   Emission-Computed;   Single-Photon
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.